 Dicerna Pharmaceuticals Inc NASDAQ:DRNA shares rose 1.3 during trading on Monday after SVB Leerink raised their price target on the stock from 43.00 to 46.00. SVB Leerink currently has an outperform rating on the stock. Dicerna Pharmaceuticals traded as high as 21.70 and last traded at 21.30, approximately 25,846 shares changed hands during trading. A ... 